Obstructive sleep apnea, hypertension, and cardiovascular risk: epidemiology, pathophysiology, and management

LA Salman, R Shulman, JB Cohen - Current Cardiology Reports, 2020 - Springer
Abstract Purpose of Review Given the rising prevalence of obstructive sleep apnea (OSA),
we aimed to review the epidemiologic and pathophysiologic relationship of OSA …

Sleep Disordered Breathing and Cardiovascular Disease: JACC State-of-the-Art Review

MR Cowie, D Linz, S Redline, VK Somers… - Journal of the American …, 2021 - jacc.org
Sleep disordered breathing causes repetitive episodes of nocturnal hypoxemia, sympathetic
nervous activation, and cortical arousal, often associated with excessive daytime sleepiness …

International consensus statement on obstructive sleep apnea

JL Chang, AN Goldberg, JA Alt… - International forum of …, 2023 - Wiley Online Library
Background Evaluation and interpretation of the literature on obstructive sleep apnea (OSA)
allows for consolidation and determination of the key factors important for clinical …

Efficacy of continuous positive airway pressure (CPAP) in the prevention of cardiovascular events in patients with obstructive sleep apnea: systematic review and meta …

G Labarca, J Dreyse, L Drake, J Jorquera… - Sleep medicine reviews, 2020 - Elsevier
Obstructive sleep apnea (OSA) commonly occurs in patients with increased cardiovascular
(CV) risk, and continuous positive airway pressure (CPAP) is the preferred therapy for these …

[HTML][HTML] Cardiovascular disease outcomes associated with obstructive sleep apnea in diabetics: a systematic review and meta-analysis

G Bushi, BK Padhi, M Shabil, P Satapathy, S Rustagi… - Diseases, 2023 - mdpi.com
Background: There is significant pathogenic and epidemiological overlap between diabetes
and obstructive sleep apnea (OSA). This systematic review aimed to ascertain the …

Continuous positive airway pressure and adverse cardiovascular events in obstructive sleep apnea: are participants of randomized trials representative of sleep clinic …

A Reynor, N McArdle, B Shenoy, SS Dhaliwal, SC Rea… - Sleep, 2022 - academic.oup.com
Abstract Study Objectives Randomized controlled trials (RCTs) have shown no reduction in
adverse cardiovascular (CV) events in patients randomized to continuous positive airway …

Cardiac consequences of intermittent hypoxia: a matter of dose? A systematic review and meta-analysis in rodents

E Belaidi, C Khouri, O Harki, S Baillieul… - European …, 2022 - Eur Respiratory Soc
Aim Intermittent hypoxia (IH) is considered to be a major contributor to obstructive sleep
apnoea-related cardiovascular consequences. The present meta-analysis aimed to assess …

[HTML][HTML] Investigating the relationship between obstructive sleep apnoea, inflammation and cardio-metabolic diseases

A Alterki, M Abu-Farha, E Al Shawaf, F Al-Mulla… - International journal of …, 2023 - mdpi.com
Obstructive sleep apnoea (OSA) is a prevalent underdiagnosed disorder whose incidence
increases with age and weight. Uniquely characterised by frequent breathing interruptions …

Validation of the STOP-Bang questionnaire as a screening tool for obstructive sleep apnoea in patients with cardiovascular risk factors: a systematic review and meta …

M Hwang, K Zhang, M Nagappa… - BMJ open …, 2021 - bmjopenrespres.bmj.com
Introduction Obstructive sleep apnoea (OSA) is highly prevalent in patients with
cardiovascular risk factors and is associated with increased morbidity and mortality. This …

Resveratrol prevents chronic intermittent hypoxia-induced cardiac hypertrophy by targeting the PI3K/AKT/mTOR pathway

P Guan, ZM Sun, N Wang, J Zhou, LF Luo, YS Zhao… - Life sciences, 2019 - Elsevier
Aims Resveratrol is a polyphenolic compound that has received much attention for its use in
ameliorating various systemic pathological conditions. The present study was performed to …